Hematology/Oncology · Coral Springs, FL
NPI
1730185299
Since 2005
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8170 Royal Palm Blvd
Coral Springs, FL, 33065
Phone (954) 755-1904
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
655 services
Medicare patients, 2024
261
Average age 76
Drug cost, 2024
$1.9M
388 prescriptions
Company payments, 2025
$804
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven Weiss was code 99214 (office e&m - established), 325 times for 159 patients. In total Steven Weiss billed 655 services in 7 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 325 | 159 | $72.86 | $24K |
| 99213 Office E&M - Established | Office | 240 | 165 | $48.43 | $12K |
| 99215 Office E&M - Established | Office | 46 | 37 | $116.34 | $5,352 |
| 99204 Office E&M - New | Office | 21 | 21 | $99.07 | $2,080 |
| 99205 Office E&M - New | Office | 20 | 20 | $147.47 | $2,949 |
By year: 2022 $51K for 737 services; 2023 $47K for 685 services; 2024 $46K for 655 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven Weiss prescribed most often to Medicare patients was Alprazolam, with 21 prescriptions and refills. In total Steven Weiss wrote 388 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 21 | 21 | Under 11 | $305 |
| Lenalidomide Generic | 18 | 18 | Under 11 | $331K |
| Hydroxyurea Generic | 17 | 36 | Under 11 | $276 |
| Anastrozole Generic | 16 | 42 | Under 11 | $201 |
| Gabapentin Generic | 15 | 33 | Under 11 | $288 |
| Jakafi Ruxolitinib Phosphate | 15 | 15 | Under 11 | $272K |
| Cerdelga Eliglustat Tartrate | 15 | 15 | Under 11 | $484K |
| Venclexta Venetoclax | 13 | 13 | Under 11 | $103K |
| Lynparza Olaparib | 12 | 12 | Under 11 | $186K |
| Pomalyst Pomalidomide | 11 | 11 | Under 11 | $240K |
| Zolpidem Tartrate Generic | 11 | 11 | Under 11 | $27.62 |
Brand drugs: 115 claims; generic drugs: 273 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Weiss $804 ($804 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 7 | $172 |
| Pfizer Inc. PFE | 7 | $133 |
| Genzyme Corporation SNY | 1 | $125 |
| Seagen Inc. PFE | 1 | $99 |
| Adaptive Biotechnologies Corporation ADPT | 2 | $71.17 |
| Merck Sharp & Dohme LLC MRK | 3 | $62.6 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $51.99 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $42.23 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $24.76 |
| Lilly USA, LLC LLY | 1 | $22.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.